Transcriptional Profiling of Peripheral Blood Mononuclear Cells in Pancreatic Cancer Patients Identifies Novel Genes with Potential Diagnostic Utility
2011

Gene Expression Analysis in Pancreatic Cancer Patients

Sample size: 59 publication 10 minutes Evidence: moderate

Author Information

Author(s): Baine Michael J., Chakraborty Subhankar, Smith Lynette M., Mallya Kavita, Sasson Aaron R., Brand Randall E., Batra Surinder K.

Primary Institution: University of Nebraska Medical Center

Hypothesis

An alteration in the global gene expression profile of PBMCs occurs in patients with pancreatic cancer.

Conclusion

The study identifies a gene predictor set that can potentially be developed for diagnostic use in pancreatic cancer.

Supporting Evidence

  • 383 genes were found to be significantly different between pancreatic cancer patients and healthy controls.
  • An eight-gene predictor set was identified that could distinguish pancreatic cancer patients from healthy controls with 79% accuracy.
  • The study highlights the potential for PBMC gene expression profiling as a diagnostic tool for pancreatic cancer.

Takeaway

Researchers looked at blood cells from pancreatic cancer patients and found specific genes that could help detect the disease early.

Methodology

PBMC samples from 26 pancreatic cancer patients and 33 matched healthy controls were analyzed using whole genome cDNA microarray.

Potential Biases

Potential biases may arise from the selection of matched controls and the variability in gene expression.

Limitations

The study's sample size is relatively small, and further validation in larger cohorts is needed.

Participant Demographics

{"gender":{"male":13,"female":13},"age":{"mean":64.4,"sd":9.0},"race":{"caucasian":21,"non_caucasian":3}}

Statistical Information

P-Value

p<0.0001

Statistical Significance

p<0.0001

Digital Object Identifier (DOI)

10.1371/journal.pone.0017014

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication